Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDIV × Lymphoma × Clear all

Status

Sponsor Class

OTHER 1439 INDUSTRY 609 NIH 289 NETWORK 128 OTHER_GOV 30 UNKNOWN 3 FED 3 INDIV 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 7 Myasthenia Gravis 4 Breast Neoplasms 4 Barrett Esophagus 4 Leiomyoma 3 Carcinoma, Hepatocellular 3 Pancreatic Neoplasms 2 Lung Neoplasms 2 Lipoma 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma in Situ 2 Warts 1 Vaginosis, Bacterial 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Syphilis 1 Sexually Transmitted Diseases 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pilonidal Sinus 1 Papillomavirus Infections 1 Overweight 1 Ovarian Neoplasms 1 Osteosarcoma 1 Obesity 1 Neutropenia 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01639716 2012-07-13

Lymphoma and T Helper 2 Cytokines Relationship With Prognostic Markers

Guler, Nil, M.D.

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡